Peterson LB et al. |
A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus. |
1998 |
Transplantation |
pmid:9448137
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients. |
2017 |
Transplantation |
pmid:27798513
|
Farid SG et al. |
Alemtuzumab (Campath-1H)-induced coagulopathy in renal transplantation. |
2009 |
Transplantation |
pmid:19502974
|
Stevens RB et al. |
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. |
2008 |
Transplantation |
pmid:18497677
|
Gurk-Turner C et al. |
Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. |
2008 |
Transplantation |
pmid:18497682
|
Rolles K et al. |
A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. |
1999 |
Transplantation |
pmid:10551650
|
Koneru B et al. |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? |
1997 |
Transplantation |
pmid:9197350
|
Sugitani A et al. |
En bloc pancreas and kidney transplantation in a patient with limited vascular access. |
1997 |
Transplantation |
pmid:9197366
|
Arns W et al. |
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial. |
2017 |
Transplantation |
pmid:28658202
|
Furukawa H et al. |
Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. |
2000 |
Transplantation |
pmid:10670633
|
Jordan ML et al. |
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. |
2000 |
Transplantation |
pmid:10670637
|
Asako H et al. |
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules. |
1992 |
Transplantation |
pmid:1384191
|
Hirose R et al. |
Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. |
2000 |
Transplantation |
pmid:10670644
|
Yun J et al. |
Bilateral ischemic optic neuropathy in a patient using tacrolimus (FK506) after liver transplantation. |
2010 |
Transplantation |
pmid:20559109
|
Furukawa H et al. |
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. |
1992 |
Transplantation |
pmid:1373531
|
Sakr M et al. |
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. |
1992 |
Transplantation |
pmid:1373535
|
Han DH et al. |
Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. |
2010 |
Transplantation |
pmid:20562737
|
Hirano Y et al. |
Morphological and functional changes of islets of Langerhans in FK506-treated rats. |
1992 |
Transplantation |
pmid:1373536
|
Hoffman AL et al. |
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. |
1990 |
Transplantation |
pmid:1690469
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Kato T et al. |
Rhabdomyolysis after kidney transplantation caused by elevated serum cyclosporine due to metabolic enzyme and transporters disorder. |
2011 |
Transplantation |
pmid:21747275
|
Ashokkumar C et al. |
Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. |
2011 |
Transplantation |
pmid:21747326
|
Berenguer M et al. |
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients. |
2010 |
Transplantation |
pmid:21068701
|
Cosio FG et al. |
Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. |
2007 |
Transplantation |
pmid:17318073
|
Budde K et al. |
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. |
2007 |
Transplantation |
pmid:17318074
|
Sindhi R et al. |
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. |
2001 |
Transplantation |
pmid:11571449
|
Casey MJ et al. |
Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure. |
2014 |
Transplantation |
pmid:24717218
|
Stifft F et al. |
Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation. |
2014 |
Transplantation |
pmid:24686426
|
Toso C et al. |
Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients. |
2003 |
Transplantation |
pmid:14557767
|
Sampaio MS et al. |
Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. |
2012 |
Transplantation |
pmid:22129761
|
Vu MD et al. |
Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts. |
2003 |
Transplantation |
pmid:12792496
|
Shibutani S et al. |
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. |
2005 |
Transplantation |
pmid:15849542
|
Tzakis AG et al. |
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. |
2003 |
Transplantation |
pmid:12792506
|
Peloso LJ et al. |
The serum concentration of tacrolimus after ingesting omeprazole: a pilot study. |
2014 |
Transplantation |
pmid:25221905
|
Koenen HJ et al. |
Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. |
2003 |
Transplantation |
pmid:12792519
|
Tory R et al. |
Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations. |
2009 |
Transplantation |
pmid:19584682
|
Jain A et al. |
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. |
2008 |
Transplantation |
pmid:18347534
|
Gallon L et al. |
Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. |
2015 |
Transplantation |
pmid:25905982
|
Weiler N et al. |
Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial. |
2010 |
Transplantation |
pmid:21048536
|
First MR |
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. |
2001 |
Transplantation |
pmid:11585240
|
Koomans HA and Ligtenberg G |
Mechanisms and consequences of arterial hypertension after renal transplantation. |
2001 |
Transplantation |
pmid:11585243
|
Tarumi K et al. |
CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. |
1999 |
Transplantation |
pmid:10071020
|
Alhamad T et al. |
Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy. |
2017 |
Transplantation |
pmid:28422926
|
Trimarchi HM et al. |
FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. |
1999 |
Transplantation |
pmid:10071024
|
Pirsch JD et al. |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9112351
|
Robertsen I et al. |
Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. |
2015 |
Transplantation |
pmid:25148382
|
Sokal EM et al. |
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. |
1997 |
Transplantation |
pmid:9392308
|
Khanna AK |
Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. |
2000 |
Transplantation |
pmid:10972232
|
Koh A et al. |
Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. |
2010 |
Transplantation |
pmid:20145529
|
Königsrainer A et al. |
Nonocclusive segmental mesenteric ischemia after combined pancreas kidney transplantation: mycophenolate mofetil as an etiological factor? |
2000 |
Transplantation |
pmid:10972233
|
Sofi AA et al. |
Bullous pemphigoid associated with acute renal allograft rejection. |
2010 |
Transplantation |
pmid:20145531
|
Gaber AO et al. |
Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. |
2008 |
Transplantation |
pmid:19005398
|
Merkle M et al. |
The effect of sevelamer on tacrolimus target levels. |
2005 |
Transplantation |
pmid:16177649
|
McDevitt-Potter LM et al. |
A multicenter experience with generic tacrolimus conversion. |
2011 |
Transplantation |
pmid:21788920
|
Eckhoff DE et al. |
Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. |
1998 |
Transplantation |
pmid:9458011
|
Roth D et al. |
Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. |
1998 |
Transplantation |
pmid:9458023
|
Gill JS et al. |
Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. |
2010 |
Transplantation |
pmid:20098280
|
Zhao W et al. |
Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child. |
2012 |
Transplantation |
pmid:22450597
|
Pascual J et al. |
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. |
2009 |
Transplantation |
pmid:19136902
|
Jacobson PA et al. |
Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. |
2012 |
Transplantation |
pmid:22334041
|
Schneeberger S et al. |
Cytomegalovirus-related complications in human hand transplantation. |
2005 |
Transplantation |
pmid:16123716
|
Ciancio G et al. |
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. |
2005 |
Transplantation |
pmid:16123718
|
Thorp M et al. |
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. |
2000 |
Transplantation |
pmid:10762229
|
Miyazawa H et al. |
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. |
1995 |
Transplantation |
pmid:7537396
|
Irish W et al. |
Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. |
2003 |
Transplantation |
pmid:14688516
|
Furlan V et al. |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. |
1995 |
Transplantation |
pmid:7537398
|
Fujii Y et al. |
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. |
1989 |
Transplantation |
pmid:2472025
|
Chisholm MA et al. |
Coadministration of tacrolimus with anti-acid drugs. |
2003 |
Transplantation |
pmid:12973105
|
Sulanc E et al. |
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. |
2005 |
Transplantation |
pmid:16249743
|
Mourad M et al. |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. |
2005 |
Transplantation |
pmid:16249748
|
Macedo C et al. |
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. |
2012 |
Transplantation |
pmid:22343334
|
McDiarmid SV et al. |
Factors affecting growth after pediatric liver transplantation. |
1999 |
Transplantation |
pmid:10030286
|
Shapiro R et al. |
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. |
1999 |
Transplantation |
pmid:10030287
|
Ericzon BG et al. |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9000664
|
Kelly PA et al. |
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. |
1997 |
Transplantation |
pmid:9000686
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Tamura K et al. |
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. |
1995 |
Transplantation |
pmid:7539960
|
Fisher A et al. |
FK506 hepatotoxicity in liver allograft recipients. |
1995 |
Transplantation |
pmid:7539961
|
Valdivia LA et al. |
Dendritic cell replacement in long-surviving liver and cardiac xenografts. |
1993 |
Transplantation |
pmid:7689265
|
Klein A et al. |
Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. |
2009 |
Transplantation |
pmid:19300186
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Beckebaum S et al. |
Predictive factors of outcome in patients transplanted for hepatitis B. |
2009 |
Transplantation |
pmid:19300191
|
Higgins R et al. |
Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation. |
2009 |
Transplantation |
pmid:19300192
|
Pascual J et al. |
Authors' reply: cyclosporine A versus tacrolimus in steroid withdrawal strategies. |
2011 |
Transplantation |
pmid:21336083
|
Steiner RW |
Steroid withdrawal in kidney transplantation: the subgroup fallacy. |
2011 |
Transplantation |
pmid:21336084
|
MacDonald A |
Improving tolerability of immunosuppressive regimens. |
2001 |
Transplantation |
pmid:11833142
|
Wang K et al. |
Transplantation of infantile bladder in rats: an alternative procedure for bladder augmentation. |
2001 |
Transplantation |
pmid:11213059
|
Mollevà DG et al. |
Heart and liver xenotransplantation under low-dose tacrolimus: graft survival after withdrawal of immunosuppression. |
2001 |
Transplantation |
pmid:11213062
|
Gruessner RW et al. |
Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. |
1998 |
Transplantation |
pmid:9701258
|
Konrad T et al. |
Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy. |
2000 |
Transplantation |
pmid:10852599
|
Schvarcz R et al. |
Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). |
2000 |
Transplantation |
pmid:10852623
|
Tsugita M et al. |
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. |
1996 |
Transplantation |
pmid:8685952
|
Lake JR et al. |
The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial. |
1995 |
Transplantation |
pmid:7482713
|
Mathew A et al. |
Reversal of steroid-resistant rejection in renal allograft recipients using FK506. |
1995 |
Transplantation |
pmid:7482730
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. |
2005 |
Transplantation |
pmid:15729180
|
Baggio B et al. |
Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. |
2005 |
Transplantation |
pmid:16314806
|
Fuchinoue S et al. |
Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal. |
2002 |
Transplantation |
pmid:11923698
|
Lauzurica R et al. |
Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation. |
2002 |
Transplantation |
pmid:11923710
|
Mayer AD et al. |
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. |
1997 |
Transplantation |
pmid:9275110
|